Tenosynovial Giant Cell Tumors, Global Pipeline Insight 2021 - Players, Drug Profiles, Therapeutics Assessment, Inactive Pipeline Products, and More
December 17, 2021 06:58 ET
|
Research and Markets
Dublin, Dec. 17, 2021 (GLOBE NEWSWIRE) -- The "Tenosynovial Giant Cell Tumors - Pipeline Insight, 2021" clinical trials has been added to ResearchAndMarkets.com's offering. This report provides...
Global TRAIL Receptor 2 Agonists Pipeline Landscape Report 2021
December 17, 2021 06:53 ET
|
Research and Markets
Dublin, Dec. 17, 2021 (GLOBE NEWSWIRE) -- The "TRAIL Receptor 2 Agonists - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides...
Global TCR Therapy Pipeline Landscape Opportunity Assessment 2021: Companies, Drugs, Therapeutics, Phases, Trends and Outlook
December 16, 2021 10:08 ET
|
Research and Markets
Dublin, Dec. 16, 2021 (GLOBE NEWSWIRE) -- The "TCR Therapy - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights...
SAB Biotherapeutics Announces SAB-185 Retains Neutralization Against Omicron SARS-CoV-2 Variant In Vitro
December 16, 2021 06:00 ET
|
SAB Biotherapeutics, Inc.
FDA laboratory testing confirms SAB-185 neutralizes Omicronand other variants of concern with in vitro pseudovirus model SAB’s targeted, highly potent and fully-human polyclonal antibodies continue...
CD47 Targeting Global Therapeutics Market 2021-2035, by Target Disease Indication, Type of Molecule Key Players and Key Geographical Regions
December 15, 2021 04:03 ET
|
Research and Markets
Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The "CD47 Targeting Therapeutics Market Industry Trends and Global Forecasts, 2021-2035" report has been added to ResearchAndMarkets.com's offering. ...
Preclinical Data Highlight the Significant Antigenic Shift of the Omicron SARS-CoV-2 Variant and its Effect on the Neutralizing Activity of Monoclonal Antibodies, Convalescent Antibodies and Vaccine-Elicited Antibodies
December 14, 2021 16:40 ET
|
Vir Biotechnology, Inc.
– Data demonstrate sotrovimab, developed by Vir in conjunction with GlaxoSmithKline, continues to retain in vitro neutralizing activity against all tested variants of concern, including Omicron – SAN...
Immunotherapy Drugs Market Outlook - Global Market Set to Reach $248.27 billion in 2025
December 13, 2021 11:38 ET
|
Research and Markets
Dublin, Dec. 13, 2021 (GLOBE NEWSWIRE) -- The "Drugs for Immunotherapy Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Global Protein Labeling Market Report 2021: Market is Expected to Reach $2.79 Billion in 2025 at a CAGR of 12% - Forecast to 2030
December 13, 2021 07:03 ET
|
Research and Markets
Dublin, Dec. 13, 2021 (GLOBE NEWSWIRE) -- The "Protein Labeling Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The...
Hepatitis Therapeutics Market - Global Forecast to 2027
December 10, 2021 03:03 ET
|
Research and Markets
Dublin, Dec. 10, 2021 (GLOBE NEWSWIRE) -- The "Hepatitis Therapeutics Market, By Disease Type (Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, Other Types), Drug Class (Interferon, Monoclonal...
Global Biosimilar Monoclonal Antibodies Market Report 2021: Market is Expected to Reach $10.92 Billion in 2025 at a CAGR of 26% with Long-term Forecast to 2030
December 09, 2021 05:23 ET
|
Research and Markets
Dublin, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The "Biosimilar Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...